title: [Treatment of rosacea. Clonidine (0.075 mg per day) versus placebo (initial results)].
authors.forename: H
authors.initials: H
authors.lastname: Van Landuyt
authors.forename: I
authors.initials: I
authors.lastname: Joubert-Lequain
authors.forename: P
authors.initials: P
authors.lastname: Humbert
authors.forename: A
authors.initials: A
authors.lastname: Lucas
authors.forename: C
authors.initials: C
authors.lastname: Drobacheff
authors.forename: M
authors.initials: M
authors.lastname: Mercier
authors.forename: R
authors.initials: R
authors.lastname: Laurent
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D003000:Clonidine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D012393:Rosacea / Q000188:drug therapy*
chemical_list: D000316:Adrenergic alpha-Agonists; D010919:Placebos; D003000:Clonidine